Kinetics and renal handling of cefonicid
- 1 November 1981
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 30 (5) , 587-593
- https://doi.org/10.1038/clpt.1981.208
Abstract
Cefonicid kinetics were determined after i.v. and i.m. injection and the renal handling of the drug was examined [in humans], including the effect of probenecid on its excretion. Peak serum levels after 1000 and 500 mg i.v. were 221 and 91 .mu.g/ml. The half-life (t1/2) was the same for both regimens (3.5 h). I.m. injection of the 1000- and 500-mg doses resulted in peak serum levels of 112 and 40 .mu.g/ml. When probenecid was given with the 500-mg dose, the peak serum level was 61 .mu.g/ml and the time to peak level rose from 1.3 to 2.5 h. The t1/2 after 1000 and 500 mg alone was much the same at 4.8 and 4.9 h. The addition of probenecid to the 500-mg dose extended the t1/2 to 7.5 h. Renal clearance, excretion and secretion rates for cefonicid were reduced by the addition of probenecid. Cefonicid''s long t1/2 and high blood levels may provide clinical efficacy with a single daily dose.This publication has 3 references indexed in Scilit:
- SK&F 75073, New Parenteral Broad-Spectrum Cephalosporin with High and Prolonged Serum LevelsAntimicrobial Agents and Chemotherapy, 1978
- Bioavailability and pharmacokinetics of cefoxitin sodiumJournal of Antimicrobial Chemotherapy, 1978
- Distribution in normal and inflammatory tissue of a new semisynthetic cephalosporin, SK&F 75073.The Journal of Antibiotics, 1978